Applied DNA Sciences has launched an expansion of its clinical testing services for the detection of Mpox to include testing for both mpox Clade I and Clade II. The launch of the expanded mpox testing service comes after ADCL’s interaction with relevant regulatory bodies, including the New York State Department of Health and the U.S. Food and Drug Administration.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APDN:
- Applied DNA Sciences receives subcontract award from LRQA
- Applied DNA submits validation package to NYS Department of Health
- Applied DNA Sciences rating updated to Under Review at H.C. Wainwright
- 3 Penny Stocks to Watch Now, 8/20/24
- Applied DNA Sciences to seek expansion of use of Linea Mpox Virus 1.0 Assay